Vanguard Group »

Cyclo Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Cyclo Therapeutics (CYTH) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Cyclo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cyclo Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cyclo Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $567k 447k 1.27
2024-03-31 $551k 397k 1.39
2023-12-31 $565k 355k 1.59
2023-09-30 $401k 282k 1.42
2023-06-30 $414k 260k 1.59
2023-03-31 $213k 254k 0.84
2022-12-31 $361k 254k 1.42
2022-06-30 $500k 254k 1.97
2022-03-31 $808k 255k 3.17
2021-09-30 $1.2M 172k 6.75
2021-06-30 $1.5M 152k 10.19
2021-03-31 $276k 34k 8.20